# Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands

> **NCT01378845** · NA · UNKNOWN · sponsor: **Christoph Hehrlein** · enrollment: 30 (estimated)

## Conditions studied

- Raynaud's Phenomenon
- Skin Necrosis

## Interventions

- **DRUG:** Tracleer
- **DRUG:** Prostavasin

## Key facts

- **NCT ID:** NCT01378845
- **Lead sponsor:** Christoph Hehrlein
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01378845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01378845, "Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01378845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*